• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22067563).
  
• Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=22067563).
  

PubMed=22067563; DOI=10.1093/neuonc/nor195; PMCID=PMC3266381
Hiroaki Wakimoto, Gayatry Mohapatra, Ryuichi Kanai, William T. Curry Jr., Stephen Yip, Mai Nitta, Anoop P. Patel, Zachary Rollins Barnard, Anat O. Stemmer-Rachamimov, David Neil Louis, Robert Lawrence Martuza, Samuel David Rabkin;
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Neuro-oncol. 14:132-144(2012)

PubMed=24726434; DOI=10.1016/j.cell.2014.02.030; PMCID=PMC4004670
Mario L. Suva, Esther Rheinbay, Shawn M. Gillespie, Anoop P. Patel, Hiroaki Wakimoto, Samuel David Rabkin, Nicolo Riggi, Andrew S. Chi, Daniel P. Cahill, Brian Vala Nahed, William T. Curry Jr. ...Show all 24 authors... , Robert Lawrence Martuza, Miguel N. Rivera, Nikki Rossetti, Simon Kasif, Samantha Beik, Sabah Kadri, Itay Tirosh, Ivo Wortman, Alex K. Shalek, Orit Rozenblatt-Rosen, Aviv Regev, David Neil Louis, Bradley E. Bernstein; Show fewer authors
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.
Cell 157:580-594(2014)

PubMed=27564115; DOI=10.18632/oncotarget.11589; PMCID=PMC5325344
Thomas J. Wilson, Daniel B. Zamler, Robert Doherty, Maria Graciela Castro, Pedro R. Lowenstein;
Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery tool.
Oncotarget 7:63020-63041(2016)